General Information of Drug (ID:
DR0686) |
Drug Name |
Fendiline
|
Synonyms |
Fendilin; Fendilina; Fendilina [INN-Spanish]; Fendiline (INN); Fendiline [INN]; Fendilinum; Fendilinum [INN-Latin]; Phendilin; Prestwick1_000270; SPBio_001131; Senzit; Spectrum2_001006; Spectrum4_000417; Spectrum5_001302; Spectrum_000443; fendiline; 13042-18-7; 3,3-diphenyl-N-(1-phenylethyl)propan-1-amine; 3,3-diphenyl-N-(1-phenylethyl)propan-1-amine;hydrochloride; AC1L1FPB; Benzenepropanamine, .gamma.-phenyl-N-(1-phenylethyl)-; Benzenepropanamine, gamma-phenyl-N-(1-phenylethyl)-; CHEMBL254832; EINECS 235-915-6; NCGC00018223-06
|
Indication |
Atherosclerosis
[ICD11: BA80]
|
Phase 4
|
[1]
|
Structure |
|
|
3D MOL
|
2D MOL
|
Pharmaceutical Properties |
Molecular Weight |
315.5 |
Topological Polar Surface Area |
12 |
Heavy Atom Count |
24 |
Rotatable Bond Count |
7 |
Hydrogen Bond Donor Count |
1 |
Hydrogen Bond Acceptor Count |
1 |
Cross-matching ID |
- PubChem CID
- 3336
- ChEBI ID
-
- CAS Number
-
- TTD Drug ID
- D02FEA
- Formula
- C23H25N
- Canonical SMILES
- CC(C1=CC=CC=C1)NCCC(C2=CC=CC=C2)C3=CC=CC=C3
- InChI
- 1S/C23H25N/c1-19(20-11-5-2-6-12-20)24-18-17-23(21-13-7-3-8-14-21)22-15-9-4-10-16-22/h2-16,19,23-24H,17-18H2,1H3
- InChIKey
- NMKSAYKQLCHXDK-UHFFFAOYSA-N
|
|
|
|
|
|
|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.